Slingshot members are tracking this event:
Oral Ozanimod Showed Histologic Improvements in Patients with Ulcerative Colitis in the Phase 2 TOUCHSTONE Trial
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Mar 18, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Ulcerative Colitis, Ozanimod, Touchstone Trial, Phase 2 Data